IRIS Institutional Research Information System - OPENBS Open Archive UniBS

ADAMO, MARIANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.206
AS - Asia 8.422
EU - Europa 4.302
SA - Sud America 2.047
Continente sconosciuto - Info sul continente non disponibili 291
AF - Africa 219
OC - Oceania 15
AN - Antartide 1
Totale 27.503
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.649
SG - Singapore 3.037
CN - Cina 1.964
BR - Brasile 1.698
HK - Hong Kong 1.291
IT - Italia 1.157
VN - Vietnam 632
DE - Germania 615
BD - Bangladesh 470
GB - Regno Unito 443
RU - Federazione Russa 392
FR - Francia 373
FI - Finlandia 322
TR - Turchia 308
CA - Canada 261
UA - Ucraina 206
IN - India 202
IE - Irlanda 175
AR - Argentina 129
NL - Olanda 93
MX - Messico 88
PL - Polonia 85
ZA - Sudafrica 77
IQ - Iraq 76
JP - Giappone 71
AT - Austria 66
SE - Svezia 65
ES - Italia 62
CZ - Repubblica Ceca 61
ID - Indonesia 57
EC - Ecuador 56
SA - Arabia Saudita 53
VE - Venezuela 43
CO - Colombia 41
PK - Pakistan 40
MA - Marocco 34
CR - Costa Rica 31
JM - Giamaica 31
BE - Belgio 26
TT - Trinidad e Tobago 26
UZ - Uzbekistan 26
EE - Estonia 25
KE - Kenya 25
PY - Paraguay 24
CL - Cile 23
HN - Honduras 22
TN - Tunisia 22
IL - Israele 21
PH - Filippine 19
AE - Emirati Arabi Uniti 18
EG - Egitto 17
NI - Nicaragua 16
CH - Svizzera 15
MD - Moldavia 15
MY - Malesia 15
PR - Porto Rico 15
GT - Guatemala 14
JO - Giordania 14
LT - Lituania 14
NP - Nepal 14
SC - Seychelles 14
SV - El Salvador 14
PE - Perù 13
AU - Australia 11
BG - Bulgaria 11
GR - Grecia 11
KZ - Kazakistan 11
UY - Uruguay 11
KR - Corea 9
LV - Lettonia 9
TH - Thailandia 9
AZ - Azerbaigian 8
GP - Guadalupe 8
HU - Ungheria 8
AL - Albania 7
DZ - Algeria 7
IR - Iran 7
PA - Panama 7
PT - Portogallo 7
RO - Romania 7
BB - Barbados 6
BO - Bolivia 6
LB - Libano 6
PS - Palestinian Territory 6
RS - Serbia 6
TW - Taiwan 6
ET - Etiopia 5
NG - Nigeria 5
BS - Bahamas 4
CY - Cipro 4
EU - Europa 4
NO - Norvegia 4
OM - Oman 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
CW - ???statistics.table.value.countryCode.CW??? 3
DM - Dominica 3
DO - Repubblica Dominicana 3
KG - Kirghizistan 3
Totale 27.156
Salva come PNG Salva come JPEG
Città #
Singapore 1.472
Hong Kong 1.285
Ashburn 1.267
San Jose 965
Council Bluffs 826
Beijing 598
The Dalles 546
Chandler 450
New York 422
Los Angeles 381
Fairfield 366
Lauterbourg 274
Princeton 249
Columbus 246
Istanbul 242
Ho Chi Minh City 224
Helsinki 222
Houston 208
Dallas 178
Seattle 177
Milan 174
Dublin 171
North Bergen 171
Santa Clara 169
São Paulo 168
Woodbridge 168
Buffalo 147
Munich 146
Wilmington 143
Moscow 138
Cambridge 131
Jacksonville 125
Redondo Beach 125
Hanoi 120
Phoenix 119
Chicago 115
Shanghai 98
Rome 94
Romola 89
San Francisco 88
Frankfurt am Main 86
Orem 85
Atlanta 74
Ann Arbor 73
London 73
Warsaw 66
Montreal 62
Nuremberg 61
Brooklyn 60
Tokyo 60
Toronto 59
Denver 52
Brescia 51
Chennai 46
Lappeenranta 46
Rio de Janeiro 46
Turku 45
Brno 44
Johannesburg 44
Boston 41
Washington 41
Brasília 40
Poplar 40
Boardman 38
Des Moines 38
Guangzhou 36
Charlotte 35
San Diego 35
Stockholm 35
Belo Horizonte 32
Amsterdam 30
Haiphong 30
Vienna 30
Düsseldorf 29
Hangzhou 27
Naples 27
Pune 26
Brussels 25
Curitiba 25
Salt Lake City 25
Turin 25
Da Nang 24
San José 24
Kyiv 23
Mexico City 23
Las Vegas 22
Manchester 22
Salvador 22
Ankara 21
Buenos Aires 21
Changsha 21
Mumbai 21
Nairobi 21
Newark 21
Porto Alegre 21
Riyadh 21
Tashkent 21
Miami 20
Baghdad 19
Brindisi 19
Totale 15.547
Salva come PNG Salva come JPEG
Nome #
May 2020 at a glance: ischaemic heart failure and sex-related differences 246
Percutaneous edge-to-edge mitral valve repair for the treatment of acute mitral regurgitation complicating myocardial infarction: A single centre experience 207
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy 203
Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry 203
Mitraclip therapy in patients with functional mitral regurgitation and missing leaflet coaptation: is it still an exclusion criterion? 200
2024 update in heart failure 197
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC 192
Self-expanding transcatheter aortic valve implantation for degenerated small Mitroflow bioprosthesis: Early and midterm outcomes 191
Effectiveness of MitraClip therapy in patients with refractory heart failure 187
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 182
EkoSonic Endovascular System for patients with acute pulmonary embolism and contraindication to systemic fibrinolysis 170
Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE-HF2 trial and comparison to COAPT and MITRA-FR trials 165
August 2020 at a glance: focus on neurohormonal antagonists and electrolytes 156
Clinical management and therapeutic optimization of patients with heart failure with reduced ejection fraction and low blood pressure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC 150
Biologically active adrenomedullin as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure: Data from STRONG-HF 139
Interaction between severe chronic kidney disease and acute kidney injury in predicting mortality after transcatheter aortic valve implantation: Insights from the Italian Clinical Service Project 136
TRIVALVE Score: A Risk Score for Mortality/Hospitalization Prediction in Patients Undergoing Transcatheter Tricuspid Valve Intervention 133
COAPT-Like Profile Predicts Long-Term Outcomes in Patients With Secondary Mitral Regurgitation Undergoing MitraClip Implantation 133
The Mayo ATTR-CM score versus other diagnostic scores and cardiac biomarkers in patients with suspected cardiac amyloidosis 131
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) 130
Transcatheter edge-to-edge mitral valve repair for post-myocardial infarction papillary muscle rupture and acute heart failure: A systematic review 129
Pathophysiology and clinical use of agents with vasodilator properties in acute heart failure. A scientific statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) 129
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 128
Advanced heart failure: guideline-directed medical therapy, diuretics, inotropes, and palliative care 126
Changes in Right Ventricular-to-Pulmonary Artery Coupling After Transcatheter Edge-to-Edge Repair in Secondary Mitral Regurgitation 126
Prognostic value of right ventricle to pulmonary artery coupling in transcatheter aortic valve implantation recipients 126
[2023 Focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure] 124
2-year outcomes of MitraClip as a bridge to heart transplantation: The international MitraBridge registry 124
[Advances in heart failure treatment: a summary of 50 years of evolution] 124
Highlights in valvular heart diseases 124
Transcatheter Mitral Valve Repair in Cardiogenic Shock and Mitral Regurgitation: A Patient-Level, Multicenter Analysis 122
Hepatic T1-time, cardiac structure and function and cardiovascular outcomes in patients with dilated cardiomyopathy 122
Role of nutrition in heart failure patients 121
[RESHAPE-HF2: new evidence and clinical implications] 120
[Italian Society of Cardiology-Italian Society of Nephrology Consensus document: The cardio-renal interaction in the prevention and treatment of cardiovascular diseases - Part II: From preventive strategies to treatment of patients with cardio-renal damage] 120
Prognostic Value of Pre-operative Atrial Fibrillation in Patients With Secondary Mitral Regurgitation Undergoing MitraClip Implantation 120
Acute heart failure and valvular heart disease: A scientific statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology 119
COVID 19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease 119
Long-Term Outcomes After Edge-to-Edge Repair of Secondary Mitral Regurgitation: 5-Year Results From the EuroSMR Registry 118
A Score to Assess Mortality After Percutaneous Mitral Valve Repair 118
Characteristics and outcomes of patients with tricuspid regurgitation and advanced heart failure 118
Derivation and Validation of a Clinical Risk Score for COAPT-Ineligible Patients Who Underwent Transcatheter Edge-to-Edge Repair 118
Role of different vascular approaches on transcatheter aortic valve implantation outcome: a single-center study. 118
MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge Registry 118
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC 117
ACE2 down-regulation may contribute to the increased thrombotic risk in COVID-19 116
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 115
Impact of COVID-2019 outbreak on prevalence, clinical presentation and outcomes of ST-elevation myocardial infarction 115
Quality of life in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: tools and evidence 115
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC 115
Highlights in heart failure 115
April 2020 at a glance: epidemiology, prevention, and biomarkers 115
Prognostic Impact of Heart Failure History in Patients with Secondary Mitral Regurgitation Treated by MitraClip 115
Characteristics and outcomes of patients with atrial versus ventricular secondary tricuspid regurgitation undergoing tricuspid transcatheter edge-to-edge repair - Results from the TriValve registry 114
January 2020 at a glance: translational medicine, predictors of outcome and treatments 114
Titration of Medications After Acute Heart Failure Is Safe, Tolerated, and Effective Regardless of Risk 114
[Italian Society of Cardiology-Italian Society of Nephrology Consensus document: The cardio-renal interaction in the prevention and treatment of cardiovascular diseases - Part I: From cardiovascular risk factors to the mechanisms of cardio-renal syndrome] 113
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study 113
Residual tricuspid regurgitation after tricuspid transcatheter edge-to-edge repair: Insights into the EuroTR registry 113
September 2019 at a glance: focus on devices 113
Trans-axillary versus trans - aortic approach for transcatheter aortic valve implantation with corevalve revalving system: insights from multicenter experience 113
Sex differences in pulmonary arterial hypertension: Insights from the FOCUS-PAH registry 112
Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention? A Pre-Specified Analysis from the ZEUS Trial 112
Prediction of mortality and heart failure hospitalisations in patients undergoing M-TEER: external validation of the COAPT risk score 111
Transcatheter therapies for tricuspid valve regurgitation 111
Congestion in Patients with Advanced Heart Failure: Assessment and Treatment 110
Life-saving transcatheter aortic valve implantation for acute severe aortic regurgitation due to rheumatoid arthritis and complicated by cardiogenic shock 110
Impact of disproportionate secondary mitral regurgitation in patients undergoing edge-to-edge percutaneous mitral valve repair 110
Transcatheter Edge-to-Edge Repair in COAPT-Ineligible Patients: Incidence and Predictors of 2-Year Good Outcome 110
Impact of Transcatheter Edge-to-Edge Mitral Valve Repair on Guideline-Directed Medical Therapy Uptitration 109
Right heart failure and mortality in patients undergoing transcatheter tricuspid valve interventions 109
Atrial fibrillation in the COVID-19 era: Simple bystander or marker of increased risk? 109
Telemedicine for the treatment of heart failure: new opportunities after COVID-19 108
Medical therapy of cardiogenic shock: Contemporary use of inotropes and vasopressors 108
Echocardiographic findings in subjects with an amyloidogenic apolipoprotein A1 pathogenic variant 107
December 2019 at a glance: economic burden, co-morbidities, and prognosis 107
Management of heart failure patients with COVID-19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology 107
Impact on clinical outcomes of right ventricular response to percutaneous correction of secondary mitral regurgitation 106
COVID-19 and Heart Failure: From Epidemiology During the Pandemic to Myocardial Injury, Myocarditis, and Heart Failure Sequelae 106
Clinical Impact of Renal Dysfunction in Patients with Severe Tricuspid Regurgitation and Chronic Heart Failure 105
Right heart failure with left ventricular assist devices: Preoperative, perioperative and postoperative management strategies. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC 105
Impact of malnutrition in patients with severe heart failure 105
[Sodium-glucose cotransporter 2 inhibitors and heart failure with preserved ejection fraction: the EMPEROR-Preserved and DELIVER studies] 104
Use of MitraClip for mitral valve repair in patients with acute mitral regurgitation following acute myocardial infarction: Effect of cardiogenic shock on outcomes (IREMMI Registry) 102
Sodium glucose co-transporter 2 inhibitors and quality of life in patients with heart failure: a comprehensive systematic review and meta-analysis of randomized controlled trials 102
Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC 101
Decongestion and Outcomes in Patients Hospitalized for Acute Heart Failure: Insights From the RELAX-AHF-2 Trial 101
[Transcatheter devices for chronic heart failure: state of the art] 101
Frailty according to the 2019 HFA-ESC definition in patients at risk for advanced heart failure: Insights from the HELP-HF registry 100
Percutaneous valve repair of functional mitral regurgitation: aiming at optimal and durable results 100
Aiming at harmony. Comparing and contrasting International HFrEF Guidelines 99
April 2022 at a glance: focus on prevention, acute heart failure and heart failure with preserved ejection fraction 99
Prevalence, Characteristics and Prognostic Impact of Aortic Valve Disease in Patients with Heart Failure and Reduced, Mildly Reduced, and Preserved Ejection Fraction: An Analysis of the ESC Heart Failure Long-Term Registry 99
Treatment of functional mitral regurgitation in chronic heart failure: can we get a 'proof of concept' from the MITRA-FR and COAPT trials? 99
Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT-CHF 98
Right ventricular deformation and right ventricular-arterial coupling in patients with heart failure due to severe aortic stenosis undergoing TAVI: long-term results. 98
2023 focused update of the 2021 ESC heart failure guidelines: Key messages for clinical practice 98
Epidemiology, pathophysiology, diagnosis and management of chronic right-sided heart failure and tricuspid regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC 97
Predicting survival in patients with severe heart failure: Risk score validation in the HELP-HF cohort 97
Staging Heart Failure Patients With Secondary Mitral Regurgitation Undergoing Transcatheter Edge-to-Edge Repair 97
Totale 12.396
Salva come PNG Salva come JPEG
Categoria #
all - tutte 169.549
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 169.549
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022498 0 0 0 0 21 57 15 76 34 51 42 202
2022/20231.347 150 48 20 115 101 377 10 144 201 19 85 77
2023/20242.078 111 39 174 150 117 243 144 62 502 79 81 376
2024/20255.393 46 47 185 502 506 433 572 304 440 607 1.067 684
2025/202611.764 1.148 1.557 898 1.730 1.062 708 1.359 529 790 939 625 419
2026/20274.425 615 477 868 2.256 209 0 0 0 0 0 0 0
Totale 27.503